Sign Up Today and Learn More About TMRW Life Sciences Stock
Invest in or calculate the value of your shares in TMRW Life Sciences or other pre-IPO companies through EquityZen's platform.
TMRW Life Sciences Stock (TMLS)
TMRW Life Sciences provides an integrated platform for automated, software-guided cryospecimen management.
About TMRW Life Sciences Stock
Founded
2018
Headquarters
New York, NY, US
Industries
Messaging and Telecommunications, Sports, Content and Publishing
TMRW is a life sciences technology company setting new standards for transparency, safety, and accountability in IVF and cell management. TMRW's platform, the world's first automated cryo-management for eggs and embryos, provides a complete digital chain of custody fully integrated with a robotic storage and monitoring solution. This is in contrast to the manual and analog methods that have gone unchanged throughout the history of IVF. With TMRW's platform, clinics significantly reduce the chances of potentially devastating errors. The TMRW team includes celebrated innovators in fertility, embryology, cryo-management, automation, software development, and robotics. TMRW is founded by Joshua Abram, Alan Murray, and Dr. Jeffrey Port in 2018 and is based in New York, New York.
TMRW Life Sciences Press Mentions
Stay in the know about the latest news on TMRW Life Sciences
Specimen holder with wireless transponder for attachment to specimen collection …
patents • Apr 02, 2025
TMRW Life Sciences Announces Launch of its Latest Offering in Frozen IVF Specimen Management and Storage: TMRW Vault™
prnewswire • Mar 19, 2025
Slotted specimen holder, wireless transponder loading cartridge, wireless …
patents • Feb 08, 2025
TMRW Life Sciences Raises $28M Series D Financing
finsmes • Sep 20, 2024
SoHo biotech raises $28M to safeguard and track embryos for IVF
crainsnewyork • Aug 03, 2024
TMRW Life Sciences Management
Leadership team at TMRW Life Sciences
Founder & Co-CEO
Joshua Abram
Board Member
Emily Drabant Conley
Join now and verify your accreditation status to gain access to:
- TMRW Life Sciences Current Valuation
- TMRW Life Sciences Stock Price
- TMRW Life Sciences Management
- Available deals in TMRW Life Sciences and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- TMRW Life Sciences Cap Table and Funding History by Share Class and Liquidity Preferences
- TMRW Life Sciences Revenue and Financials
- TMRW Life Sciences Highlights
- TMRW Life Sciences Business Model
- TMRW Life Sciences Risk Factors
- TMRW Life Sciences Research Report from SACRA Research
Trading TMRW Life Sciences Stock
How to invest in TMRW Life Sciences stock?
Accredited investors can buy pre-IPO stock in companies like TMRW Life Sciences through EquityZen funds. These investments are made available by existing TMRW Life Sciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell TMRW Life Sciences stock?
Shareholders can sell their TMRW Life Sciences stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
